Priyanka Kulkarni

722 total citations
35 papers, 557 citations indexed

About

Priyanka Kulkarni is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Priyanka Kulkarni has authored 35 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 16 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Priyanka Kulkarni's work include Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (10 papers) and MicroRNA in disease regulation (9 papers). Priyanka Kulkarni is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (10 papers) and MicroRNA in disease regulation (9 papers). Priyanka Kulkarni collaborates with scholars based in United States, India and Japan. Priyanka Kulkarni's co-authors include Marisa Shiina, Soichiro Yamamura, Rajvir Dahiya, Yuichiro Tanaka, Yutaka Hashimoto, Shahana Majid, Varahram Shahryari, Pritha Dasgupta, Sharanjot Saini and Guoren Deng and has published in prestigious journals such as PLoS ONE, Cancer Research and The FASEB Journal.

In The Last Decade

Priyanka Kulkarni

31 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priyanka Kulkarni United States 12 391 330 105 70 32 35 557
Catalina Perdomo United States 8 426 1.1× 392 1.2× 117 1.1× 52 0.7× 24 0.8× 11 682
Yuxin Wen China 11 265 0.7× 194 0.6× 73 0.7× 55 0.8× 52 1.6× 17 428
Qiong-Ni Zhu China 10 446 1.1× 426 1.3× 44 0.4× 73 1.0× 47 1.5× 13 597
Yuxia Zhao China 12 193 0.5× 126 0.4× 69 0.7× 79 1.1× 26 0.8× 26 313
Isaac Yi Kim South Korea 13 397 1.0× 256 0.8× 115 1.1× 57 0.8× 24 0.8× 21 602
Vilma Maldonado Mexico 9 189 0.5× 162 0.5× 70 0.7× 95 1.4× 27 0.8× 11 394
Rory L. Cochran United States 11 156 0.4× 169 0.5× 80 0.8× 95 1.4× 21 0.7× 34 481
Xiaodong Ling China 12 219 0.6× 141 0.4× 93 0.9× 77 1.1× 27 0.8× 34 371

Countries citing papers authored by Priyanka Kulkarni

Since Specialization
Citations

This map shows the geographic impact of Priyanka Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priyanka Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priyanka Kulkarni more than expected).

Fields of papers citing papers by Priyanka Kulkarni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priyanka Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priyanka Kulkarni. The network helps show where Priyanka Kulkarni may publish in the future.

Co-authorship network of co-authors of Priyanka Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Priyanka Kulkarni. A scholar is included among the top collaborators of Priyanka Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priyanka Kulkarni. Priyanka Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wirtz, Veronika J., et al.. (2022). Commercial and Social Value of Pharmaceutical Industry-led Access Programs: Conceptual Framework and Descriptive Analysis. Health Systems & Reform. 8(1). e2057831–e2057831. 1 indexed citations
2.
Dauria, Emily, Priyanka Kulkarni, Angelo Clemenzi-Allen, Lauren Brinkley‐Rubinstein, & Curt G. Beckwith. (2022). Interventions Designed to Improve HIV Continuum of Care Outcomes for Persons with HIV in Contact with the Carceral System in the USA. Current HIV/AIDS Reports. 19(4). 281–291. 11 indexed citations
3.
Kulkarni, Priyanka, Pritha Dasgupta, Yutaka Hashimoto, et al.. (2021). A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis. Cancer Research. 81(6). 1500–1512. 42 indexed citations
4.
Shiina, Marisa, Yutaka Hashimoto, Priyanka Kulkarni, et al.. (2021). Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans. BMC Cancer. 21(1). 1028–1028. 8 indexed citations
5.
Kulkarni, Priyanka, Hemant Tongaonkar, Hemangi Chaudhari, et al.. (2021). Polymorphism of interleukin-6 -174 G/C (rs1800795) & the corresponding interleukin-6 level as a prognostic marker of cervical cancer. The Indian Journal of Medical Research. 154(2). 391–398. 3 indexed citations
6.
Hashimoto, Yutaka, Marisa Shiina, Shigekatsu Maekawa, et al.. (2021). Suppressor effect of catechol-O-methyltransferase gene in prostate cancer. PLoS ONE. 16(9). e0253877–e0253877. 6 indexed citations
7.
Dasgupta, Pritha, Priyanka Kulkarni, Nadeem S. Bhat, et al.. (2020). Activation of the Erk/MAPK signaling pathway is a driver for cadmium induced prostate cancer. Toxicology and Applied Pharmacology. 401. 115102–115102. 26 indexed citations
8.
Kulkarni, Priyanka & Jayant Londhe. (2020). An Insight into the Coronavirus. ACTA SCIENTIFIC MICROBIOLOGY. 3(10). 70–74. 1 indexed citations
9.
Dasgupta, Pritha, Priyanka Kulkarni, Shahana Majid, et al.. (2020). LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma. Cell Death and Disease. 11(8). 660–660. 47 indexed citations
10.
Imai-Sumida, Mitsuho, Priyanka Kulkarni, Marisa Shiina, et al.. (2020). Genistein Represses HOTAIR/Chromatin Remodeling Pathways to Suppress Kidney Cancer. Cellular Physiology and Biochemistry. 54(1). 53–70. 44 indexed citations
11.
Kulkarni, Priyanka, Pritha Dasgupta, Nadeem S. Bhat, et al.. (2020). Role of the PI3K/Akt pathway in cadmium induced malignant transformation of normal prostate epithelial cells. Toxicology and Applied Pharmacology. 409. 115308–115308. 21 indexed citations
12.
Hashimoto, Yutaka, Marisa Shiina, Pritha Dasgupta, et al.. (2019). Upregulation of miR-130b Contributes to Risk of Poor Prognosis and Racial Disparity in African-American Prostate Cancer. Cancer Prevention Research. 12(9). 585–598. 22 indexed citations
13.
Dasgupta, Pritha, Priyanka Kulkarni, Nadeem S. Bhat, et al.. (2019). Abstract 4659: Cadmium induced malignant transformation involves activation of the Erk/MAPK pathway. Cancer Research. 79(13_Supplement). 4659–4659. 1 indexed citations
14.
Joshi, Shashank, et al.. (2019). Efficacy of DPP4i as the Fourth Drug in the Management of Type2 Diabetes Mellitus in Asian Indians Poorly Controlled by Use of at least 3 Oral Antidiabetic Drugs.. PubMed. 67(8). 60–62. 3 indexed citations
15.
Dasgupta, Pritha, Priyanka Kulkarni, Shahana Majid, et al.. (2018). MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma. Molecular Cancer Therapeutics. 17(5). 1061–1069. 82 indexed citations
16.
Kulkarni, Priyanka, Pritha Dasgupta, Nadeem S. Bhat, et al.. (2018). Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression. Molecular Cancer Research. 16(11). 1750–1760. 44 indexed citations
17.
Thombre, Rebecca, Priyanka Kulkarni, Felipe Gómez, & Bhalamurugan Sivaraman. (2018). Extremophiles from Tirez and Peña Hueca: Implications for exploring habitability of Mars and Europa. EPSC. 1 indexed citations
18.
Kato, Taku, Yutaka Hashimoto, Shigekatsu Maekawa, et al.. (2017). Abstract 2288: Effects of tobacco smoking and alcohol consumption on risks of CYP1B1 polymorphisms for prostate cancer. Cancer Research. 77(13_Supplement). 2288–2288.
19.
Imai-Sumida, Mitsuho, Takeshi Chiyomaru, Shahana Majid, et al.. (2017). Abstract 199: Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways. Cancer Research. 77(13_Supplement). 199–199. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catalina Perdomo Breakdown of academic impact, for papers by Yuxin Wen Breakdown of academic impact, for papers by Qiong-Ni Zhu Breakdown of academic impact, for papers by Yuxia Zhao Breakdown of academic impact, for papers by Isaac Yi Kim Breakdown of academic impact, for papers by Vilma Maldonado Breakdown of academic impact, for papers by Rory L. Cochran Breakdown of academic impact, for papers by Xiaodong Ling
Rankless by CCL
2026